Contact us

Our People

Meet our experienced team of leaders and scientific experts.

The leadership team all have several decades of big pharma industrial experience and have been responsible for delivering numerous products through development to launch while our experienced team of scientists are all experts in their chosen field. If you wish to contact any of our team with a specific question or enquiry you can do so below and they will be happy to help. Expect a reply typically within 48 hours.

View our team by expertise

SELECT EXPERTISE

  • All Expertise
  • Oral Drug Delivery
  • DMPK Consultancy and Dose Selection
  • Pharmacokinetic Modelling
  • Complex Medicines
  • Paediatric Product Development
  • CMC Regulatory
  • Clinical Pharmacology

Leadership Team

Expertise:

  • Oral Drug Delivery
  • Complex Medicines
  • Paediatric Product Development
  • CMC Regulatory

Paul W Stott

BPharm (Hons) PhD

Chief Executive Officer

Paul W Stott

BPharm (Hons) PhD

Chief Executive Officer

View Bio Ask me a question

Paul is an established pharma executive with extensive global experience. Prior to joining Seda he was Vice President, Global Product Development at AstraZeneca, leading a group of over 350 scientists and engineers in the development of all products, manufacturing processes and analytical methods for the AstraZeneca small molecule portfolio.

AstraZeneca Global Product Development has centres in the UK, Sweden, US and China and a network of partnerships with colleagues all over the world and under Paul’s stewardship registered 10 global products.

At AstraZeneca Paul was accountable for the Drug Product CMC component of all Due Diligence assessments and was CMC lead on several multibillion dollar acquisitions. In addition, Paul is a visiting Professor of Pharmaceutics at the University of Manchester, UK and founder of the North West Centre for Drug Delivery (NoWCADD) at the University.

He is a proven senior manager and strategic leader in Pharmaceutical Development with experience across geographical boundaries. Passionate about the development of individual and group capabilities and the application of innovation and scientific rigour to bring new medicinal products to market.

He is recognised within the Industry and with Regulatory Agencies as a driving force in the establishment and realisation of best practice in CMC Quality by Design.

Ask me a question

    Expect a reply typically within 48 hours.

    Expertise:

    • Oral Drug Delivery
    • Complex Medicines
    • Paediatric Product Development
    • CMC Regulatory
    • Analytical Sciences

    Marcel de Matas

    BSc (Hons) PhD FRSC CChem

    Chief Technology Officer & Co-Founder

    Marcel de Matas

    BSc (Hons) PhD FRSC CChem

    Chief Technology Officer & Co-Founder

    View Bio Ask me a question

    Marcel has a track record in a range of management and senior scientific positions in industry and academia. Most recently he was a Principal Scientist in Product Design and Innovation at AstraZeneca, where he was responsible for introducing the latest science, new technologies (advanced drug delivery and manufacturing) and product design thinking into the Product Development group.

    Marcel has led technical activities, provided project leadership and has managed product development teams responsible for the delivery of drug projects from initial concept design through late stage development, regulatory submission and launch (including advanced drug delivery systems). He has led teams at the drug discovery-development interface, assessing the level of chemistry manufacturing and controls (CMC) technical risk and defining product design strategies in early development. Project experience has covered projects across a range of disease and therapy areas with substantial experience in the oncology field.

    Ask me a question

      Expect a reply typically within 48 hours.

      Expertise:

      • DMPK Consultancy and Dose Selection
      • Pharmacokinetic Modelling
      • Complex Medicines
      • CMC Regulatory
      • Clinical Pharmacology
      • Analytical Sciences

      Paul A Dickinson

      BPharm (Hons) PhD

      Chief Scientific Officer & Co-Founder

      Paul A Dickinson

      BPharm (Hons) PhD

      Chief Scientific Officer & Co-Founder

      View Bio Ask me a question

      Paul has held several senior science leadership roles in Academia and Large Pharma.  These roles focused on applying the best science in projects to ensure optimal product performance in the patient, thus bridging pharmaceutical and clinical disciplines.

       

      Immediately prior to founding Seda Pharmaceutical Development Services Paul was Senior Clinical Pharmacology Scientist at AstraZeneca and led the clinical pharmacology program to NDA/MAA for AZD9291/osimertinib, which had been awarded ‘breakthrough therapy’ status by the FDA.  Formerly Paul was a Principal Scientist within Pharmaceutical Development (AZ) leading both the global biopharmaceutics network and the Medicines Evaluation science community (USA, SE, UK).

       

      Paul has been at the forefront of recent advances in the understanding of in vitro performance criteria that assure product performance in the patient including clinically relevant dissolution specifications (CRDS).  Paul has co-authored papers with FDA staff focussed on efforts to combine biopharmaceutics with ICH Q8 (BioRAM) and is past Chair of the AAPS ‘QbD and product performance’ focus group.

      ‪Paul A Dickinson‬ – ‪Google Scholar‬

      Ask me a question

        Expect a reply typically within 48 hours.

        Expertise:

        • Oral Drug Delivery
        • Paediatric Product Development

        Shanoo Budhdeo

        BSc (Hons)

        Director: Pharmaceutical Sciences

        Shanoo Budhdeo

        BSc (Hons)

        Director: Pharmaceutical Sciences

        View Bio Ask me a question

        Shanoo is an experienced pharmaceutical development scientist with many years’ experience in large pharma and the biotech sector. She has a particular interest in biopharmaceutics, development of clinically relevant in vitro tests and the development of products for paediatrics.

        Ask me a question

          Expect a reply typically within 48 hours.

          Expertise:

          • Complex Medicines
          • Clinical Pharmacology

          Claire Patterson

          MPharm (Hons) PhD

          Director: Pharmaceutical Sciences

          Claire Patterson

          MPharm (Hons) PhD

          Director: Pharmaceutical Sciences

          View Bio Ask me a question

          Claire Patterson is Senior Principal Scientist at Seda with a Master of Pharmacy (MPharm) and a Ph.D. in Pharmaceutics from the Universities of Nottingham and University College London respectively. Claire is an experienced Biopharmaceutics scientist having spent 12 years with former employer AstraZeneca with roles in Early and Late Stage Product Development, linking in vitro to in vivo product performance. Current focus areas include subcutaneous and complex parenteral biopharmaceutics (including nanomedicines) and other non-oral routes of administration.

          ‪Claire Patterson‬ – ‪Google Scholar‬

          Ask me a question

            Expect a reply typically within 48 hours.

            Expertise:

            • Oral Drug Delivery
            • DMPK Consultancy and Dose Selection
            • Pharmacokinetic Modelling
            • Clinical Pharmacology

            Linette Ruston

            BSc (Hons) PhD

            Director: ADME and Modelling Sciences

            Linette Ruston

            BSc (Hons) PhD

            Director: ADME and Modelling Sciences

            View Bio Ask me a question

            Linette is a Senior Principal Scientist at Seda with a BSc (Hons) and PhD in Chemistry from Universities of Glasgow and Edinburgh, respectively.  She is an experienced Biopharmaceutics and DMPK scientist having spent 17+ years with AstraZeneca where she held roles in Discovery and Early Pharmaceutical Development, providing expert physicochemical, ADME and Biopharmaceutics input into compound design and selection, and applied knowledge of in vitro, in silico and in vivo models to enable material choice and project progression from discovery to early clinical development.  Her current focus is on translation of DMPK/PD and biopharmaceutics understanding into meaningful product and clinical study design within Seda.

            Ask me a question

              Expect a reply typically within 48 hours.

              Expertise:

              • Human Resources

              Faye Briffa

              BA (Hons) FCIPD

              HR Business Partner

              Faye Briffa

              BA (Hons) FCIPD

              HR Business Partner

              View Bio Ask me a question

              After a 20 year career in HR working primarily in the Pharmaceutical Industry, Faye Briffa set up Ashfield HR, an HR Consultancy supporting North West based small and medium sized companies who have no in-house HR capability. Faye is CIPD qualified having achieved a Post Graduate Diploma in HR Management from Manchester Metropolitan University in 2002. Since then, she has held a variety of HR roles, including in Recruitment, Employment, Business Change and HR Business Partnering.

              Ask me a question

                Expect a reply typically within 48 hours.

                Our Team

                Expertise:

                • Analytical Sciences
                • Chemical Development
                • Complex Medicines
                • CMC Regulatory

                Effi Baetzner

                PhD

                Principal Scientist

                Effi Baetzner

                PhD

                Principal Scientist

                View Bio Ask me a question

                Effi is a Principal Scientist working in Analytical Sciences at Seda. Since her MSc and PhD and throughout, she has been working with Oligonucleotides/RNA, their synthesis, analysis and in the last 4 years – their pharmaceutical testing in a GxP environment. Coming from an organic Chemistry background and having worked with big biomolecules, she has experience in a multitude of different analytical techniques and their troubleshooting.

                With her leadership experience in a CRO, she has the skills to work for Seda as a technical leader to ensure the quality of analytical data is excellent and the customers’ needs are met.

                ‪Effi Bätzner‬ – ‪Google Scholar‬

                 

                Ask me a question

                  Expect a reply typically within 48 hours.

                  Expertise:

                  • Analytical Sciences

                  Tahera Begum

                  Bsc (Hons)

                  Scientist

                  Tahera Begum

                  Bsc (Hons)

                  Scientist

                  Tahera Begum has 2 years’ analytical experience working in the Cannabis Industry. She has previously worked on formulation of cannabinoid-based products including food and cosmetics, where her main responsibilities included analysis of cannabinoid content in final formulations using HPLC. At SEDA Tahera hopes to continue building on her analytical expertise and move towards pharmaceutical drug development.

                  Expertise:

                  • Complex Medicines
                  • Oral Drug Delivery

                  Alexander Clout

                  BSc (Hons) PhD

                  Senior Scientist

                  Alexander Clout

                  BSc (Hons) PhD

                  Senior Scientist

                  Alex has a background in chemistry and holds a PhD in pharmaceutics from University College London, during which he gained extensive experience in the solid-state characterisation of pharmaceutical materials, including polymorphism and co-crystallisation, combining both thermal and structural analyses to develop a full picture of the changes occurring when materials undergo phase transitions. More recently he has worked on projects in formulation development with a particular focus on the microfluidic manufacture of nanomaterials for administration of sustained release parenterals. He also has valuable experience in the development and manufacture of oral solid dosage forms.

                  Kati de Matas

                  BSc (Hons)

                  Finance Assistant

                  Kati de Matas

                  BSc (Hons)

                  Finance Assistant

                  Kati is a first-class maths graduate from Keele University and has 1.5 years’ experience working for a marketing and advertising agency. With a mathematical background, she has a particular interest in finance management and accounting. Kati provides support within all areas of the business, to enhance efficiency and productivity, including procurement, finance management and marketing.

                  Expertise:

                  • Pharmacokinetic Modelling

                  Harri Dickinson

                  BSc (Hons)

                  Modeller

                  Harri Dickinson

                  BSc (Hons)

                  Modeller

                  Harri is able to apply commercially available software PK-Sim, in order to form translational PB-PK modelling for different species or populations and help with dose selection in the early clinical stage settings. As a Mathematics graduate his background enables him to bring systems thinking to PK modelling to identify sources of uncertainty and risk.

                  ‪Harri Dickinson‬ – ‪Google Scholar‬

                  Expertise:

                  • Pharmacokinetic Modelling

                  Jake Dickinson

                  BSc (Hons)

                  Associate Principal Modeller

                  Jake Dickinson

                  BSc (Hons)

                  Associate Principal Modeller

                  View Bio Ask me a question

                  A physics graduate, with over 3 years’ experience in the pharmaceutical industry. Jake has applied analytical, mathematical, and problem-solving skills to the assessment of the likelihood of drug candidate success and to identify the likely risks involved in the formulation of a drug. Areas of expertise include PK / PK-PD-TGI modelling in preclinical species and translation to man to aid in dose prediction. Jake has developed models and applications including Nora Max, an in silico absorption model, that aids decision making in late preclinical and early clinical drug development phases of drug development and enables the identification of the formulation technologies required for FiH.

                  ‪Jake Dickinson‬ – ‪Google Scholar‬

                  Ask me a question

                    Expect a reply typically within 48 hours.

                    Expertise:

                    • Pharmacokinetic Modelling

                    Jingrao Fei

                    BSc (Hons) MSc

                    Modeller

                    Jingrao Fei

                    BSc (Hons) MSc

                    Modeller

                    BSc in Pharmaceutical Science, MSc in Model-based Drug Development from the University of Manchester. At Seda, Jingrao’s role is to create translational PB-PK modelling for various species or populations and assist with dose selection in early clinical stage settings.

                    Expertise:

                    • Pharmacokinetic Modelling

                    Emily Fell

                    MEng (Hons)

                    Modeller

                    Emily Fell

                    MEng (Hons)

                    Modeller

                    First from the University of Birmingham studying Mechanical Engineering with a final year focus in biomedical engineering. Using my academic background with my interest in this area, I will be working with the modelling team within Seda.

                    Expertise:

                    • Pharmacokinetic Modelling

                    Parmesh Gajjar

                    BA (Hons) MMath PhD

                    Principal Scientist

                    Parmesh Gajjar

                    BA (Hons) MMath PhD

                    Principal Scientist

                    View Bio Ask me a question

                    Parmesh has a strong mathematical background with a BA (Hons) & MMath from the University of Cambridge and a PhD in Applied Mathematics from the University of Manchester. He has 8 years of pharmaceutical experience, across both orally inhaled products and pharmacometrics. For 5+ years Parmesh worked on the physical characterisation of inhalation medicines alongside large Pharma and Contract Drug Manufacturing Organisations (CDMOs). Parmesh has more than two years of experience in pharmacometrics.

                    At Seda, Parmesh works on pharmacokinetic and pharmacodynamic modelling. He has published on Population PK modelling and been an invited speaker at a FDA/CRCG workshop on modelling integrated approaches for long-acting injectables. He has a range of experience across preclinical and clinical PK-PD modelling, including absorption and dissolution modelling alongside performing NCA.

                    ‪Parmesh Gajjar‬ – ‪Google Scholar‬

                    Ask me a question

                      Expect a reply typically within 48 hours.

                      Expertise:

                      • Analytical Sciences

                      Toby Goodall-Munroe

                      MChem

                      Scientist

                      Toby Goodall-Munroe

                      MChem

                      Scientist

                      Toby is an MChem graduate from the University of Sheffield, focused on the development and characterisation of novel metal-organic nanosheets within the Foster research group. Areas of experience include analytical science and chemical development. Toby formally joined SEDA as an analytical scientist in 2021.

                      Expertise:

                      • Oral Drug Delivery
                      • Complex Medicines

                      Lorraine Jones

                      BSc (Hons)

                      Senior Scientist

                      Lorraine Jones

                      BSc (Hons)

                      Senior Scientist

                      Lorraine has over 20 years’ high quality laboratory experience at a leading global pharmaceutical company and one of the world’s leading toxicology laboratories. She is experienced in most aspects of drug development and toxicology, ranging from pre-clinical toxicology through to human clinical trials.

                      Expertise:

                      • Complex Medicines

                      Fanny Joubert

                      BSc (Hons) PhD

                      Senior Scientist

                      Fanny Joubert

                      BSc (Hons) PhD

                      Senior Scientist

                      Fanny has a bachelor’s degree in chemistry, an engineer diploma in Materials Science and a PhD in Polymer Chemistry. Following her studies, she worked as a Research Associate for 6+ years in both Academia and large Pharma focussing on polymers for healthcare and precision nanomedicine applications. She joined Seda as Senior Scientist to facilitate the development of complex parenterals using her knowledge of nanotechnology.

                      Expertise:

                      • Oral Drug Delivery
                      • CMC Regulatory
                      • Analytical Sciences

                      Arun Kamath

                      MChem (Hons)

                      Associate Principal Scientist

                      Arun Kamath

                      MChem (Hons)

                      Associate Principal Scientist

                      View Bio Ask me a question

                      Arun Kamath is an Associate Principal Scientist in Analytical Sciences at Seda. He has a Master of Chemistry (MChem) from the University of Leeds, with over 14 years’ experience in the global pharmaceutical industry. His area of expertise is in analytical sciences for drug product development, which has involved working with a wide range of analytical techniques and developing a comprehensive understanding of drug project analytical strategy requirements and critical product quality attributes.

                      Ask me a question

                        Expect a reply typically within 48 hours.

                        Expertise:

                        • Oral Drug Delivery

                        Wang Wang Lee

                        MPharm (Hons) PhD GPhC

                        Principal Scientist

                        Wang Wang Lee

                        MPharm (Hons) PhD GPhC

                        Principal Scientist

                        View Bio Ask me a question

                        Wang Wang Lee is a GPhC registered pharmacist with a PhD in Pharmaceutical Sciences and MBA from the University of Strathclyde. She has deep industry and academic experience particularly in the areas of biopharmaceutics and product development. Her expertise in early and late-stage development, risk assessing and mitigating the development challenges has helped clients transition compounds into the clinic from discovery.

                        ‪Wang Wang Lee‬ – ‪Google Scholar‬

                        Ask me a question

                          Expect a reply typically within 48 hours.

                          Expertise:

                          • Oral Drug Delivery
                          • Analytical Sciences

                          Vivien Lin

                          BSc (Hons) MRes

                          Scientist

                          Vivien Lin

                          BSc (Hons) MRes

                          Scientist

                          Biomaterial and tissue engineering graduate with a MRes in regenerative medicine. Working in the pharmaceutical industry for 1 year. Focus on analytical and formulation development for both preclinical and clinical studies.

                          Expertise:

                          • Oral Drug Delivery
                          • Complex Medicines

                          Essyrose Mathew

                          BSc (Hons) PhD

                          Senior Scientist

                          Essyrose Mathew

                          BSc (Hons) PhD

                          Senior Scientist

                          Essy has a pharmaceutical science background with a PhD from Queen’s University Belfast. During her PhD she worked on 3D printed systems for transdermal drug delivery and the use of microfluidics for nanoparticle fabrication along with extensive experience in a range of analytical characterisation techniques. At Seda she will use her experience in pharmaceutics within the formulation development team, focusing on oral dosage forms and complex medicines.

                          Expertise:

                          • Oral Drug Delivery
                          • CMC Regulatory

                          Pankaj Mittal

                          BPharm (Hons) MS

                          Technical Director

                          Pankaj Mittal

                          BPharm (Hons) MS

                          Technical Director

                          View Bio Ask me a question

                          Pankaj has held several senior product development & technology transfer leadership roles in Large & Mid-size Pharma introducing new manufacturing technologies, product innovation & design to expedite the overall drug development pathway.

                          Pankaj has managed product development and technical teams responsible for delivering products to the patients from FTiH through late-stage development, linking regulatory and launch activities in multiple international markets. Passionate about the technical capability build with the application of robust Quality by Design & Quality Risk Management principles, Pankaj will enhance the technical product robustness and business development function at Seda.

                          Ask me a question

                            Expect a reply typically within 48 hours.

                            Expertise:

                            • Analytical Sciences

                            Bethany Nelson

                            BSc (Hons)

                            Senior Scientist

                            Bethany Nelson

                            BSc (Hons)

                            Senior Scientist

                            Bethany has a first-class degree in medicinal and biological chemistry and 5+ years of pharmaceutical analytical method development experience in a CDMO environment. Bethany’s focus is on U/HPLC and dissolution analysis, with experience in leading analytical projects from initial method establishment through to GMP validation and supporting formulation development. At Seda, Bethany will be developing fit-for-purpose analytical methods for a variety of drug products.

                            Expertise:

                            • Oral Drug Delivery
                            • CMC Regulatory

                            Nicola Parisi

                            MSc PhD

                            Principal Scientist

                            Nicola Parisi

                            MSc PhD

                            Principal Scientist

                            View Bio Ask me a question

                            Nicola holds a MSc in Pharmaceutical Chemistry from the University of Messina and a PhD in Pharmaceutics from UCL School of Pharmacy. He is an accomplished Formulation Scientist with 9+ years’ experience in the field and roles at AstraZeneca and GlaxoSmithKline. He additionally holds a qualification from the Association for Project Management (PFQ). He is expert in planning, leading and managing clinical drug product development projects and has a deep understanding of change control, risk and stakeholder management processes.

                            ‪Nicola Parisi‬ – ‪Google Scholar‬

                            Ask me a question

                              Expect a reply typically within 48 hours.

                              Expertise:

                              • Analytical Sciences

                              Alan Raoof

                              BSc MSc

                              Senior Scientist

                              Alan Raoof

                              BSc MSc

                              Senior Scientist

                              Alan is an overseas Pharmacist with 9 years’ experience in the pharmacy environment. He has an MSc degree with distinction in Drug Design and Discovery from the University of Salford, and another MSc in Pharmaceutical Analysis from the University of Strathclyde. Alan has experience working as a QC analyst for almost 2 years in a GMP environment, and has worked for 2 years as an assistant lecturer in the School of Pharmacy at University of Sulaimani. He has special interests in characterisation of pharmaceutical materials, nanomedicines, analytical method development and utilising spectroscopy and chromatography in chemical and bioanalysis.

                              ‪Alan Raoof‬ – ‪Google Scholar‬

                              Expertise:

                              • Oral Drug Delivery
                              • Analytical Sciences

                              Elen Roberts

                              BSc (Hons)

                              Senior Scientist

                              Elen Roberts

                              BSc (Hons)

                              Senior Scientist

                              First class Medical Science graduate with 1.5 years experience working in the pharmaceutical industry. Areas of focus include formulation development for both preclinical and clinical studies across a range of administrative routes and indications, including the use of amorphous solid dispersions to enhance the solubility of poorly soluble compounds.

                              Expertise:

                              • Analytical Sciences

                              Emily Stables

                              BSc MSc

                              Scientist

                              Emily Stables

                              BSc MSc

                              Scientist

                              Emily Stables has a first-class BSc in Chemistry and MSc with Distinction in Drug Discovery, Development and Delivery with a project on Immunomodulating Brain Targeting Peptide-Based Nanoparticles. She also has experience working with analytical techniques such as PXRD, HPLC, IR, NMR, DSC, TGA and flow cytometry Emily’s areas of focus at Seda will be formulation development for preclinical and clinical studies alongside analytical development. 

                              Libby Stott

                              Lab Assistant

                              Libby Stott

                              Lab Assistant

                              Libby Stott joined Seda following her A level studies. She works to ensure the efficient running of the laboratory including material receipt and coordination, Health and Safety aspects and lab organisation. She also acts as a primary contact for all aspects of Facility Management.

                              Expertise:

                              • Analytical Sciences

                              Elizabeth Wright

                              BSc (Hons)

                              Scientist

                              Elizabeth Wright

                              BSc (Hons)

                              Scientist

                              Elizabeth studied chemistry at the University of Sheffield and has been working as an analytical scientist for past 7 years. She has a broad range of experience in using different analytical techniques, such as HPLC, GC-MS, ICP-OES, Karl Fisher, XRF. She also has experience of testing clinical samples for toxicology and is keen to focus on method development. 

                              Expertise:

                              • Oral Drug Delivery

                              Talbir Austin

                              BSc (Hons) PhD CChem MRSC

                              Associate - Material Sciences

                              Talbir Austin

                              BSc (Hons) PhD CChem MRSC

                              Associate - Material Sciences

                              View Bio Ask me a question

                              Dr Talbir (Tal) Austin is a consultant providing expertise in solid state, material design and characterisation, and development with particular focus on the early development phase.

                              Dr Austin is a structural organic chemist who has worked within the pharmaceutical industry for nearly three decades. Her previous positions involved complex problem solving and troubleshooting of projects – overseeing material design, selection and development, from the Preclinical phase through to Early Development at AstraZeneca. She also led the design and implementation of AstraZeneca’s material selection strategy at the discovery and development interface. Dr Austin has extensive experience in optimising material properties for different therapy areas (Respiratory, Inflammation, CNS, CV, GI and Oncology) and modes of administration; oral, inhalation, parenteral, topical.

                              Ask me a question

                                Expect a reply typically within 48 hours.

                                Expertise:

                                • Analytical Sciences
                                • CMC Regulatory

                                Peter Doyle

                                BSc (Hons) MSc PhD

                                Associate - Analytical Sci.

                                Peter Doyle

                                BSc (Hons) MSc PhD

                                Associate - Analytical Sci.

                                View Bio Ask me a question

                                Peter has worked in the pharmaceutical and healthcare sector for over 25 years with leadership and scientific positions at J&J, AstraZeneca and Glaxo. He has extensive experience in the management of outsourced projects with a focus on analytical development activities. Peter has authored many regulatory submissions from FiH to NDA / MAA and has an expert understanding of the regulatory requirements at each stage of development. He has been a consultant to the biotech sector since 2017.

                                Ask me a question

                                  Expect a reply typically within 48 hours.

                                  Expertise:

                                  • Complex Medicines
                                  • Oral Drug Delivery

                                  Paul Gellert

                                  BA DPhil

                                  Associate - Complex Medicines

                                  Paul Gellert

                                  BA DPhil

                                  Associate - Complex Medicines

                                  View Bio Ask me a question

                                  Paul has 33+ years’ experience in Drug Discovery and Development at AstraZeneca, specialising in novel formulation, drug delivery and product design. He has led many projects and teams in identifying, evaluating and designing novel viable drug delivery-based products and new drug delivery technologies across a broad range of routes of administration and drug modalities including many complex medicines.

                                  From 2017 to 2021, in additional to his role as Senior Principal Scientist in Drug Delivery, Paul was the Science & Innovation Director for Drug Delivery and Product Design, accountable for driving and championing science and innovation in drug delivery and product design to create new implementable business opportunities. Paul started and led AstraZeneca’s Global Novel Drug Delivery Network for many years and is widely recognised outside AstraZeneca as an expert on drug delivery technologies and the external drug delivery environment, including patent and intellectual property aspects.

                                  Paul has collaborated extensively with academic groups and drug delivery companies and is the co-author and co-inventor of a number of publications and patent applications. He has been a member of a range of external groups including Editorial advisory board member for the Nanomedicine journal, Scientific Advisory Board member and Programme Chair for the Controlled Release Society Conference, Scientific Consultant to the Wellcome Trust and EPSRC programme External Advisory Board member.

                                   

                                  Ask me a question

                                    Expect a reply typically within 48 hours.

                                    Expertise:

                                    • CMC Regulatory

                                    Roy Jamieson

                                    BPharm (Hons)

                                    Associate - Regulatory CMC

                                    Roy Jamieson

                                    BPharm (Hons)

                                    Associate - Regulatory CMC

                                    View Bio Ask me a question

                                    Roy is an experienced Pharma Industry & Regulatory CMC professional having spent time as a quality assessor at MHRA and with over 25 years in large pharma organisations leading numerous small molecule projects from FTiH through Marketing Authorisation and launch. As an Independent Consultant he has worked with many small companies as well as collaborating with consultancy firms and is currently supporting the South African Agency (SAHPRA) as a Quality/CMC reviewer supporting their generic backlog programme.

                                    Roy has successfully led 4 major global submissions through Phase 3 to marketing authorisation approval. His key area of regulatory scientific expertise and interest centres on biopharmaceutics aspects of solid oral dosage forms of small molecules and the bridge between quality performance and the pharmacokinetic profile linked to safety and efficacy.

                                    Ask me a question

                                      Expect a reply typically within 48 hours.

                                      Expertise:

                                      • Chemical Development
                                      • CMC Regulatory

                                      Bill Moss

                                      BSc (Hons) PhD

                                      Associate - Chem. Dev.

                                      Bill Moss

                                      BSc (Hons) PhD

                                      Associate - Chem. Dev.

                                      View Bio Ask me a question

                                      Dr Bill Moss has over 25 years’ experience as a scientist and leader working in the following areas:

                                      • Chemical Development and manufacture of clinical and commercial drug substance
                                      • Expertise in the Discovery interface, Preclinical and Phase1/Phase II development, supporting the progression of new candidate drugs from discovery into development
                                      • Drug substance project strategy development and integration with drug product, safety and clinical planning
                                      • Extensive experience of outsourcing drug substance development and manufacture
                                      • Authoring and reviewing regulatory submissions from Phase I to marketing submissions

                                      Ask me a question

                                        Expect a reply typically within 48 hours.